Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2017-10-23 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2017
Transaction in Own Shares Classification · 99% confidence The document explicitly details transactions made under Novozymes' stock buyback program, providing accumulated totals, daily transaction breakdowns (number of shares, average price, transaction value), and detailed trade logs. This content directly relates to the company purchasing its own shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (Code: POS). It is not an earnings release, quarterly report, or annual report, but a specific disclosure about share repurchase activity.
2017-10-23 English
Transaction in Own Shares 2017
Transaction in Own Shares Classification · 100% confidence The document text is very short (261 characters) and explicitly states that Novozymes has bought back a specific number of shares under a previously announced share repurchase program ('aktietilbagekøbsprogram'). This action directly relates to the company buying back its own stock. The final line, 'Læs hele meddelelsen i PDF' (Read the full announcement in PDF), suggests this is a brief notification rather than the full detailed report. The most specific category for reporting the company buying back its own shares is 'Transaction in Own Shares' (POS). Since it's a brief announcement pointing to a PDF, it could potentially be RPA, but the content is highly specific to share repurchase, making POS the primary classification.
2017-10-23 Danish
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 90% confidence The document reports on Novozymes’ stock buyback program and the accumulated shares purchased, indicating a company transaction in its own shares. This matches the “Transaction in Own Shares” category.
2017-10-23 English
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement from Novozymes regarding their share buy-back program. It details the number of shares purchased, the transaction values, and provides a comprehensive appendix of individual trade data. This type of filing, which reports on the company's own share transactions, is classified as 'Transaction in Own Shares' (POS).
2017-10-23 English
Transaction in Own Shares 2017
Transaction in Own Shares Classification · 100% confidence The document text explicitly states that Novozymes has purchased an accumulated number of shares under a 'stock buyback program'. This action directly relates to the company acquiring its own shares. The filing category that covers the report of the company buying back or selling its own shares is 'Transaction in Own Shares' (POS). Although the text mentions reading the full announcement in PDF, the content itself is the core information about the share repurchase activity, making POS the most specific classification, rather than RPA or RNS, as the core subject matter is present.
2017-10-16 English
Transaction in Own Shares 2017
Transaction in Own Shares Classification · 100% confidence The document text is very short (262 characters) and explicitly states that Novozymes has bought back shares under a previously announced program ('aktietilbagekøbsprogram'). It concludes with 'Læs hele meddelelsen i PDF' (Read the full announcement in PDF). This structure—a brief summary of a transaction followed by a pointer to the full document—strongly suggests this is an announcement about a transaction in own shares (share repurchase). The most specific code is POS (Transaction in Own Shares). Although it points to a PDF, the content itself describes the transaction, making POS more accurate than RPA or RNS, as the core subject is the share repurchase activity.
2017-10-16 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.